HENDERSON, NV--(Marketwired - Mar 19, 2015) - Rx Safes, Inc. (OTC: RXSF), the developer of fingerprint enabled healthcare security products and secure prescription medicine lock-boxes, announced today that its CEO, Lorraine Yarde, was invited to appear on the show to discuss the importance of locking up all medications in the home. Also interviewed on the show was the Director of the Oklahoma Bureau of Narcotics and Dangerous Drugs, Darrell Weaver, who is a 25+ year law enforcement veteran, his experience dealing primarily with Narcotics based crimes and issues.

1 in 5 teenagers in the US has admitted to abusing prescription drugs and 70% of these drugs are stolen from the medicine cabinets of unsuspecting family members and friends. Show host, Josh Tolley, implored his listeners to purchase the company's product, the Rx DrugSAFE, stating, "This issue is a matter of life and death...and it's preventable with a product like the Rx DrugSAFE." Josh added, "Why would you take the risk when we have over 100,000 deaths every year as a result of prescription drugs."

Director Weaver emphasized the importance of personal responsibility, saying that we have to deal with this issue one home at a time. "I would like to get multiple lockboxes…I would like one in every home of our elderly in Oklahoma," Director Weaver added. The Oklahoma Bureau of Narcotics has led the way in spearheading initiatives to address the prescription drug abuse epidemic within their state. They recently validated the importance of our product by purchasing 500 Rx DrugSAFE units, which they will install in the homes of elderly Oklahomans.

"Following the successful installation of these initial 500 lockboxes in Oklahoma, we expect to work on a more comprehensive program to fulfill Director Weaver's wishes of a lockbox in the home of very elderly person in Oklahoma. We are now seeing interest from other states, including Florida and Massachusetts and are working on programs with officials from various departments, to make the Rx DrugSAFE available in their respective states," commented Rx Safes' CEO, Lorraine Yarde.

Also on the call was a brave recovering addict, Kris Kesterson, who became addicted to prescription drugs at the age of 13 when he began stealing them from the medicine cabinet at home. 17 years on, Kris is still battling addiction and stated, "If they had been locked up I wouldn't have had access to them and it definitely would have deterred me."

Rx Safes' patented fingerprint technology makes it simple for families to provide a safe environment for their children at home. Without needing to remember a pin code or find a key, the Rx DrugSAFE provides true peace of mind to responsible parents without negatively impacting their daily routine.

The interview offers valuable insight into the prescription drug abuse issue from different viewpoints and can be heard in full at the following link: https://youtu.be/bPPk4eMqGaE

About Rx Safes, Inc.

Rx Safes is an emerging leader in the personal and professional healthcare drug security market. Since drug abuse and drug diversion starts with unauthorized access, our products incorporate proprietary patented fingerprint technology to provide drug security solutions for use in homes and healthcare facilities. Prescription drug misuse, skyrocketing insurance and pharmaceutical treatment costs and increased regulatory pressures create an unfortunate, yet necessary opportunity for Rx Safes to expand our reach and offerings in this growing market, valued at over $50 billion annually. Annual spending on healthcare technology products exceeds $34.5 billion. In addition, the market is being driven by ongoing Government support for successful drug abuse prevention initiatives, with a financial commitment of $25.4 billion in 2015 alone. For more information, please visit www.rxdrugsafe.com.

Forward-Looking Statements for RXSF:
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact Information:


Farialle Pacha
Account Manager
1140 - 121 King Street West
Toronto, ON M5H 3T9
T. 416.644.2020
Montreal Office: T. 514.939.3989

Like us on Facebook at https://www.facebook.com/rx.drugsafe
Follow us on Twitter at https://twitter.com/RxDrugSAFE